HomeDOSE • CNSX
add
Rapid Dose Therapeutics Corp
Previous close
$0.16
Day range
$0.16 - $0.18
Year range
$0.15 - $0.31
Market cap
24.02M CAD
Avg Volume
31.50K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | May 2025info | Y/Y change |
|---|---|---|
Revenue | 782.74K | 96.18% |
Operating expense | 895.76K | -25.94% |
Net income | -723.68K | 42.42% |
Net profit margin | -92.45 | 70.65% |
Earnings per share | — | — |
EBITDA | -461.22K | 48.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | May 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 72.50K | -35.88% |
Total assets | 3.99M | 119.90% |
Total liabilities | 9.31M | 81.85% |
Total equity | -5.32M | — |
Shares outstanding | 131.89M | — |
Price to book | -4.00 | — |
Return on assets | -44.80% | — |
Return on capital | 95.51% | — |
Cash Flow
Net change in cash
| (CAD) | May 2025info | Y/Y change |
|---|---|---|
Net income | -723.68K | 42.42% |
Cash from operations | -434.90K | 30.11% |
Cash from investing | 899.00 | — |
Cash from financing | 489.65K | -14.74% |
Net change in cash | 51.78K | 207.88% |
Free cash flow | -267.57K | 29.08% |
About
Founded
2008
Headquarters
Website
